REVELATION BIOSCIENCES, INC. Proceeds from Sale and Maturity of Marketable Securities
REVELATION BIOSCIENCES, INC. (REVB) reported Proceeds from Sale and Maturity of Marketable Securities of $525.29 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2021-12-31 was $37.10K.
- REVELATION BIOSCIENCES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2021-09-30 was $281.97K.
- REVELATION BIOSCIENCES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2021-06-30 was $71.58K.
- REVELATION BIOSCIENCES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2021-03-31 was $134.64K.
- REVELATION BIOSCIENCES, INC. proceeds from sale and maturity of marketable securities for fiscal 2021 was $525.29K.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $37.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $319.07K derived: sum of 2 quarters · filed 2022-04-15 | $390.65K derived: sum of 3 quarters · filed 2022-04-15 | $525.29K 10-K · filed 2022-04-15 |
| 2021-09-30 | $281.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $353.54K derived: sum of 2 quarters · filed 2021-10-29 | $488.18K 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $71.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $206.22K 10-Q · filed 2021-08-23 | ||
| 2021-03-31 | $134.64K 10-Q · filed 2021-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |